Remifentanil and Atropine for Intubation in Neonates
Phase 4
Completed
- Conditions
- Endotracheal Intubation
- Interventions
- Drug: Atropine/RemifentanilDrug: Fentanyl/Atropine/Succinylcholine
- Registration Number
- NCT00815048
- Lead Sponsor
- King Saud University
- Brief Summary
The investigators hypothesize that the use of a combination of Atropine and Remifentanil will safely facilitate non emergent intubation procedure as effectively as the protocol of Atropine, Fentanyl, and Succinylcholine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Hemodynamically stable neonates of any gestational age admitted to the Neonatal Intensive Care Unit at McMaster Children's Hospital requiring an elective endotracheal intubation was anticipated.
Exclusion Criteria
- Urgent intubations
- Cyanotic congenital heart lesions
- Anticipated difficult airway
- Concurrent or recently administered (within 3 hours of the procedure) intravenous opioid infusions
- Pre-existing hyperkalemia
- Family history of malignant hyperthermia
- Prior enrollment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Remifentanil Atropine/Remifentanil Atropine Remifentanil Fentanyl Fentanyl/Atropine/Succinylcholine Atropine Fentanyl Succinylcholine
- Primary Outcome Measures
Name Time Method Time to Successful intubation 15 minutes
- Secondary Outcome Measures
Name Time Method Time to return of spontaneous respirations 15 minutes Oxygen saturation During the procedure up to 15 minutes Heart Rate During the procedure up to 15 minutes Blood Pressure During the procedure up to 15 minutes Intubation Condition 15 minutes post procedure Evidence of Trauma 15 minutes post procedure
Trial Locations
- Locations (1)
McMaster University NICU
🇨🇦Hamilton, Ontario, Canada